Windtree Therapeutics, Inc.

WINT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2-$20-$39-$68
Dep. & Amort.$0$0$1$0
Deferred Tax-$0$0-$1-$10
Stock-Based Comp.$0$1$3$7
Change in WC$1$2-$2-$0
Other Non-Cash-$15$3$19$47
Operating Cash Flow-$15-$13-$19-$24
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0$0-$0
Financing Activities
Debt Repay.$1-$1-$1-$4
Stock Issued$5$12$4$27
Stock Repurch.$0$0$0$0
Dividends Paid-$1$0$0$0
Other Fin. Act.$7$1$0$6
Financing Cash Flow$13$12$3$29
Forex Effect$0$0$0$0
Net Chg. in Cash-$3-$2-$16$5
Supplemental Information
Beg. Cash$4$6$23$17
End Cash$2$4$6$23
Free Cash Flow-$15-$13-$19-$24
Windtree Therapeutics, Inc. (WINT) Financial Statements & Key Stats | AlphaPilot